Biotech Merdury signs MOU with Health2Sync to conduct trial of Merdury’s StackDose technology intended for usage in GLP-1 (semaglutide) medication July 25, 2024
Biotech Ariceum Therapeutics Commences Phase 1 Clinical Trial in Patients with Recurrent Glioblastoma July 25, 2024
Biotech A Novel Way to Reduce Alzheimer’s Amyloid Plaque Burden, Phase 2 Clinical Trial Results of T3D-959 to be Presented by T3D Therapeutics at AAIC July 24, 2024
Biotech Aragen Life Sciences Ltd. receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery and Development Services July 24, 2024
Biotech Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class July 23, 2024
Biotech Nasal Polyposis Treatment Market to Reach US$ 6.8 Bn by 2034, Fueled by Rising Demand for Non-invasive Options: Transparency Market Research, Inc. July 23, 2024
Biotech Diamyd Medical receives positive feedback from FDA on potential Accelerated Approval for Diamyd® in Type 1 Diabetes July 23, 2024
Biotech Theravance Biopharma to Report Second Quarter 2024 Financial Results on August 5, 2024 July 22, 2024
Biotech Onassis Holdings Retained Investment Bank Dalmore Group to Launch up to $75 Million Regulation A+ Offering (Mini IPO) July 22, 2024
Biotech Astellas and Graduate School of Medicine / Faculty of Medicine, Osaka University Enter into Research Collaboration to Develop Pluripotent Stem Cell-Derived Cartilage Organoid Cell Therapy July 22, 2024